ARCHIVES

Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December

This article is from The Cancer Letter archive.

Vol. 40 No. 35 | September 19, 2014

Download PDF Visit The Full Archive

Related Articles

U. Arizona Center Finds a Way To Community Rapport

January 18, 1980

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004

Consolidation Unlikely to Save Money

December 17, 2010

Yarbro Refuses To Seek Core Renewal, Quits Director Post

September 22, 1978

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984